ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update

ISDA letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives from February 12, 2014.

Appendix 1: Update on each of the industry issues and challenges advised previously (Appendix 2).
Appendix 2: Original list of industry issues and challenges.

Documents (3) for ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update